V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017222 | 220014193 | 0 | 98 | Disease modification (D) | 2015-04-16 | 2015-04-19 | Dasatinib | 02 | N | 220029424 | DASATINIB |
| 220017223 | 220007617 | 1.58 | 140 | Curative (C) | 2013-11-18 | 2013-11-18 | AML 18 TRIAL | Y | N | 220029428 | AML18 TRIAL |
| 220017224 | 220007617 | null | null | Disease modification (D) | 2017-02-12 | 2017-02-12 | Dasatinib | 02 | N | 220029428 | DASATINIB |
| 220017225 | 220007619 | 1.56 | 74.4 | Curative (C) | 2017-10-03 | 2017-10-08 | Alemtuz+Fludara+Melphalan RIC MUD | Y | null | 220029439 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017226 | 220007621 | 0 | 72 | Adjuvant (A) | 2016-08-07 | 2016-08-07 | Rituximab | N | N | 220029442 | RITUXIMAB |
| 220017227 | 220017745 | 1.84 | 110 | Curative (C) | 2014-01-14 | 2014-01-15 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029445 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017228 | 220007627 | 1.81 | 88.7 | null | 2016-11-13 | 2017-02-23 | AML 18 TRIAL | null | N | 220029453 | AML18 TRIAL |
| 220017229 | 220007629 | 1.66 | 64.9 | Curative (C) | 2013-12-24 | 2014-03-11 | AML18 PILOT TRIAL | N | N | 220029454 | PILOT TRIAL |
| 220017231 | 220007634 | 1.65 | 81.6 | Curative (C) | null | 2016-06-30 | AML 18 Pilot Trial | N | null | 220029467 | PILOT TRIAL |
| 220017232 | 220014203 | 1.68 | 76 | null | 2015-10-18 | 2015-10-18 | Rituximab | N | null | 220029470 | RITUXIMAB |
| 220017233 | 220007641 | 1.68 | 66 | Curative (C) | 2013-04-07 | 2013-04-07 | AML 18 TRIAL | null | N | 220029478 | AML18 TRIAL |
| 220017234 | 220007643 | null | null | Curative (C) | 2017-08-15 | 2017-08-19 | Dasatinib | N | N | 220029485 | DASATINIB |
| 220017235 | 220014207 | 1.63 | 57.6 | Curative (C) | 2015-11-12 | 2015-11-20 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029493 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017237 | 220007648 | 1.61 | 57.8 | Curative (C) | 2013-07-04 | 2013-07-11 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220029500 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017238 | 220017750 | 1.7 | 63.3 | Disease modification (D) | 2017-11-27 | 2017-11-27 | Dasatinib | N | N | 220029506 | DASATINIB |
| 220017239 | 220007650 | null | 60.8 | null | 2013-12-12 | 2014-01-21 | AML18 PILOT TRIAL | 1 | N | 220029507 | PILOT TRIAL |
| 220017240 | 220020887 | 1.56 | null | Curative (C) | 2013-11-15 | 2013-11-22 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029514 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017241 | 220007652 | null | 0 | Curative (C) | 2017-06-10 | 2017-06-10 | Dasatinib | 2 | N | 220029514 | DASATINIB |
| 220017242 | 220019737 | 1.71 | 85.6 | Curative (C) | 2017-04-28 | 2017-05-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220029522 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017243 | 220007654 | 1.67 | 75 | Curative (C) | 2014-06-07 | 2014-06-12 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029523 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017244 | 220007654 | 1.62 | 76 | Curative (C) | 2016-07-19 | 2016-07-31 | AML18 PILOT TRIAL | Y | N | 220029523 | PILOT TRIAL |
| 220017245 | 220007656 | 1.76 | null | Curative (C) | 2013-05-13 | 2013-05-13 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029537 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017246 | 220007657 | 1.77 | null | Disease modification (D) | 2015-04-27 | 2015-04-29 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220029540 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017249 | 220007660 | 1.77 | 76.2 | Disease modification (D) | 2014-04-07 | 2014-04-07 | Rituximab | N | N | 220029568 | RITUXIMAB |
| 220017250 | 220007662 | 1.63 | 42.5 | Curative (C) | 2013-09-23 | 2013-09-24 | AML 18 TRIAL | 1 | N | 220029586 | AML18 TRIAL |
| 220017251 | 220017760 | 1.6 | 67.8 | Curative (C) | 2018-02-20 | 2018-02-20 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220029591 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017252 | 220007666 | 1.71 | 74.9 | Curative (C) | 2016-08-14 | 2016-08-14 | Rituximab | N | N | 220029599 | RITUXIMAB |
| 220017253 | 220007671 | 1.61 | 80.5 | Curative (C) | 2015-01-15 | 2015-03-03 | AML18 PILOT TRIAL | Y | N | 220029606 | PILOT TRIAL |
| 220017254 | 220017762 | 1.8 | 82.8 | Curative (C) | 2017-08-18 | 2017-08-18 | AML 18 Pilot Trial | N | N | 220029608 | PILOT TRIAL |
| 220017255 | 220014226 | null | 77 | Adjuvant (A) | 2015-03-25 | 2015-05-15 | AML18 PILOT TRIAL | 01 | N | 220029610 | PILOT TRIAL |
| 220017256 | 220017763 | null | 67 | Palliative (P) | 2018-09-21 | 2018-09-21 | Dasatinib | N | N | 220029612 | DASATINIB |
| 220017257 | 220017763 | 1.59 | null | Curative (C) | null | 2016-05-12 | Rituximab | N | N | 220029612 | RITUXIMAB |
| 220017259 | 220014228 | 1.88 | null | Curative (C) | 2017-12-14 | 2017-12-16 | Dasatinib | 99 | N | 220029628 | DASATINIB |
| 220017260 | 220020891 | 1.64 | 52 | Curative (C) | 2018-02-03 | 2018-03-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029630 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017261 | 220007683 | 1.88 | null | Palliative (P) | 2014-11-18 | 2014-12-15 | Dasatinib | 02 | N | 220029636 | DASATINIB |
| 220017262 | 220017765 | 1.63 | 82.2 | Disease modification (D) | null | 2015-06-25 | Dasatinib | N | N | 220029639 | DASATINIB |
| 220017263 | 220014231 | 1.54 | 55 | Curative (C) | 2018-12-29 | 2018-12-29 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029651 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017264 | 220007685 | 1.74 | 57 | Curative (C) | 2017-11-09 | 2017-11-20 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029660 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017265 | 220007686 | 1.71 | null | Curative (C) | 2014-06-01 | 2014-06-22 | Dasatinib | N | null | 220029662 | DASATINIB |
| 220017266 | 220007689 | 0 | 69.9 | Curative (C) | 2013-09-04 | 2013-10-16 | AML18 PILOT TRIAL | N | N | 220029664 | PILOT TRIAL |
| 220017267 | 220019746 | 1.67 | 56 | Curative (C) | 2017-04-21 | 2017-04-28 | Dasatinib | 02 | N | 220029666 | DASATINIB |
| 220017268 | 220007690 | 1.73 | 111.2 | Curative (C) | 2013-09-21 | 2013-09-21 | AML 18 TRIAL | N | N | 220029667 | AML18 TRIAL |
| 220017269 | 220017769 | null | 0 | null | null | 2014-09-14 | Dasatinib | 02 | N | 220029672 | DASATINIB |
| 220017271 | 220007698 | 1.6 | 63 | Curative (C) | 2017-06-24 | 2017-07-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029688 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017272 | 220007705 | 1.78 | null | Curative (C) | 2017-01-17 | 2017-01-17 | Rituximab | N | null | 220029704 | RITUXIMAB |
| 220017273 | 220020892 | 1.58 | 55.6 | null | 2017-09-01 | 2017-10-02 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220029705 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220017274 | 220021530 | 1.56 | 60.7 | Not known (9) | 2017-06-28 | 2017-06-28 | Dasatinib | N | N | 220029706 | DASATINIB |
| 220017275 | 220007708 | 1.6 | 51.5 | Curative (C) | 2013-04-12 | 2013-06-28 | AML 18 Pilot Trial | 1 | N | 220029714 | PILOT TRIAL |
| 220017276 | 220007708 | 1.64 | 77 | Disease modification (D) | 2014-08-13 | 2014-10-15 | Rituximab | 2 | N | 220029714 | RITUXIMAB |
| 220017278 | 220007711 | 1.7 | 88.9 | Disease modification (D) | 2014-02-08 | 2014-06-21 | Dasatinib | N | Y | 220029736 | DASATINIB |